Recommendation ID
NG231/05A
Question

Frequency and duration of endoscopic follow-up: What is the optimal frequency and duration of endoscopic follow-up for patients who have received endoscopic treatment for Barrett's oesophagus with dysplasia?

Any explanatory notes
(if applicable)

For a short explanation of why the committee made this recommendation for research, see the rationale section on managing Barrett's oesophagus with dysplasia.

Full details of the evidence and the committee's discussion are in evidence review J: endoscopic and radiological follow-up after treatment.


Source guidance details

Comes from guidance
Barrett's oesophagus and stage 1 oesophageal adenocarcinoma: monitoring and management
Number
NG231
Date issued
February 2023

Other details

Is this a recommendation for the use of a technology only in the context of research? No  
Is it a recommendation that suggests collection of data or the establishment of a register?   No  
Last Reviewed 28/02/2023